-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on CVS Health, Raises Price Target to $82

Benzinga·08/01/2025 14:15:40
Listen to the news
Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $80 to $82.